Stocktoria
COLLEGIUM PHARMACEUTICAL, INC COLL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-05-07
COLLEGIUM PHARMACEUTICAL, INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 59.3% | 59.8% | 57.5% | 45.2% | 54.4% |
| Operating margin | 23.0% | 26.9% | 29.5% | 7.2% | 6.4% |
| Net margin | 8.1% | 11.0% | 8.5% | -5.4% | 25.8% |
| FCF margin | 42.0% | 32.2% | 48.4% | 26.4% | 36.7% |
| Return on assets | 3.8% | 4.2% | 4.2% | -2.1% | 10.3% |
| Return on equity | 20.8% | 30.2% | 24.6% | -12.8% | 35.2% |
| Current ratio | 1.57 | 0.95 | 1.17 | 0.97 | 1.13 |
| Revenue growth | 23.6% | 11.4% | 22.2% | 67.6% | -10.7% |
Source: SEC EDGAR filings · CIK 0001267565 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.